Affinity Asset Advisors’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.08M | Buy |
606,678
+125,000
| +26% | +$1.87M | 1.24% | 24 |
|
|
2025
Q1 | $7.77M | Sell |
481,678
-342,650
| -42% | -$5.53M | 0.74% | 25 |
|
|
2024
Q4 | $19.2M | Buy |
824,328
+325,908
| +65% | +$7.59M | 2.57% | 10 |
|
|
2024
Q3 | $14.7M | Sell |
498,420
-15,000
| -3% | -$441K | 2% | 15 |
|
|
2024
Q2 | $12.1M | Buy |
513,420
+103,420
| +25% | +$2.43M | 1.39% | 19 |
|
|
2024
Q1 | $15.6M | Sell |
410,000
-107,554
| -21% | -$4.08M | 1.93% | 13 |
|
|
2023
Q4 | $11.1M | Buy |
517,554
+275,257
| +114% | +$5.92M | 2.03% | 18 |
|
|
2023
Q3 | $2.97M | Buy |
242,297
+46,297
| +24% | +$567K | 0.83% | 29 |
|
|
2023
Q2 | $2.21M | Buy |
+196,000
| New | +$2.21M | 0.77% | 32 |
|